Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANI Pharmaceuticals Inc.

www.anipharmaceuticals.com

Latest From ANI Pharmaceuticals Inc.

Deal Watch: BMS To Tap Early-Stage Breakthroughs In Partnership With BioMotiv

Bristol-Myers Squibb will partner with the biotech accelerator to fund and launch biotechs, with the pharma getting an option to buy. Novartis signs another agreement with IFM months after buying its IFM Tre affiliate.

Deals Business Strategies

ANI Pharma Looks to Buy A Platform For Its Push Into Injectables

Having swelled its pipeline of US injectable drugs through an acquisition, ANI Pharmaceuticals is on the lookout for attractive manufacturing assets.

Business Strategies M & A

ANI Strikes Deal With Coeptis For Seven Development-Stage Assets

Continuing its acquisition streak, ANI Pharmaceuticals has bought a pipeline of seven development-stage generics from Coeptis Pharmaceuticals for $2.3m in cash and up to $12m in development and commercial milestone payments.

Deals Strategy

ANI Pledges To Keep Snapping Up Assets And Partnering

US niche generics and brands player ANI Pharmaceuticals intends to keep using its cash flow to fund product acquisitions and partnerships, particularly in the injectables arena.


Business Strategies Deals
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Generic Drugs
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • ANIP Acquisition Co.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ANI Pharmaceuticals Inc.
  • Senior Management
  • Arthur S Przybyl, Pres. & CEO
    Stephen P Carey, VP, CFO
    Robert W Schrepfer, SVP, Bus. Dev. & Spec. Sales
  • Contact Info
  • ANI Pharmaceuticals Inc.
    Phone: (218) 634-3500
    210 Main St. W.
    Baudette, MN 56623
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register